0000913849-15-000056.txt : 20150218 0000913849-15-000056.hdr.sgml : 20150216 20150217164743 ACCESSION NUMBER: 0000913849-15-000056 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150217 DATE AS OF CHANGE: 20150217 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: GENOCEA BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001457612 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-87984 FILM NUMBER: 15623694 BUSINESS ADDRESS: STREET 1: 100 ACORN PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617-876-8191 MAIL ADDRESS: STREET 1: 100 ACORN PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: GENOCEA BIOSCIENCES INC DATE OF NAME CHANGE: 20090304 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CVF, LLC CENTRAL INDEX KEY: 0001112278 IRS NUMBER: 367227242 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 222 NORTH LASALLE STREET STREET 2: SUITE 2000 CITY: CHICAGO STATE: IL ZIP: 60601 BUSINESS PHONE: 312-899-5034 MAIL ADDRESS: STREET 1: 222 NORTH LASALLE STREET STREET 2: SUITE 2000 CITY: CHICAGO STATE: IL ZIP: 60601 FORMER COMPANY: FORMER CONFORMED NAME: CVF LLC DATE OF NAME CHANGE: 20000419 SC 13G 1 sc13g_021315.htm GENOCEA BIOSCIENCES, INC. SCHEDULE 13G sc13g_021315.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
__________
 
SCHEDULE 13G

 
Under the Securities Exchange Act of 1934
 
(Amendment No. __)*
 

Genocea Biosciences, Inc.
(Name of Issuer)
 
Common Stock, $0.001 par value per share
(Title of Class of Securities)
 
372427104
(CUSIP Number)
 
December 31, 2014
(Date of Event Which Requires Filing of this Statement)
 
 

 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
o      Rule 13d-1(b)
o      Rule 13d-1(c)
ý      Rule 13d-1(d)
 
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 
 
 
CUSIP No. 372427104
13G
Page 2 of 5 Pages

1.
NAME OF REPORTING PERSON
 
CVF, LLC
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP                                                                  (a) o
 
                                                                                                                                                                              (b) o
 
3.
SEC USE ONLY
 
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:
5.
SOLE VOTING POWER
 
1,218,740
6.
SHARED VOTING POWER
 
—
7.
SOLE DISPOSITIVE POWER
 
1,218,740
8.
SHARED DISPOSITIVE POWER
 
—
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
1,218,740
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
                                                                                                                                                                              o
 
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
6.9%
12.
TYPE OF REPORTING PERSON
 
OO



 
 
  

 
- 2 -
 
CUSIP No. 372427104
13G
Page 3 of 5 Pages


 
Item 1(a).
Name of Issuer:
 
Genocea Biosciences, Inc.
 
Item 1(b).
Address of Issuer’s Principal Executive Offices:
 
 
100 Acorn Park Drive, Fifth Floor, Cambridge, Massachusetts 02140
 
Item 2(a).
Name of Person Filing:
 
 
CVF, LLC (“CVF”)
 
Item 2(b).
Address of Principal Business Office or, if none, Residence:
 
 
222 N. LaSalle Street, Suite 2000, Chicago, Illinois 60601
 
Item 2(c).
Citizenship:
 
 
Delaware
 
Item 2(d).
Title of Class of Securities:
 
 
Common Stock, $0.001 par value per share
 
Item 2(e).
CUSIP Number:
 
 
372427104
 
Item 3.
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), indicate type of person filing.
 
Not applicable
 
Item 4.
Ownership.
 
 
(a)
 
Amount beneficially owned:  See row 9 of the cover page.
 
(b)
 
Percent of class:  See row 11 of the cover page.
 
(c)
 
Number of shares as to which such person has:
 
 
 
(i)      Sole power to vote or direct the vote:  See row 5 of the cover page.
 
 
 
(ii)     Shared power to vote or direct the vote:  See row 6 of the cover page.
 
 
 
(iii)    Sole power to dispose or to direct the disposition of:  See row 7 of the cover page.
 
 
 
(iv)    Shared power to dispose or to direct the disposition of:  See row 8 of the cover page.
 
 
 
 
  

 
- 3 -
 
CUSIP No. 372427104
13G
Page 4 of 5 Pages


 
 
Percent of class is based on (i) the number of shares held by CVF as of December 31, 2014 and (ii) the number of shares of common stock outstanding as of November 3, 2014 (17,610,154 shares) as reported by the Issuer in its most recent Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 6, 2014.
 
Item 5.
Ownership of Five Percent or Less of a Class.
 
 
Not applicable.
 
Item 6.
Ownership of More than Five Percent on Behalf of Another Person.
 
 
Not applicable
 
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
 
 
Not applicable.
 
Item 8.
Identification and Classification of Members of the Group.
 
 
Not applicable.
 
Item 9.
Notice of Dissolution of Group.
 
 
Not applicable.
 
Item 10.
Certifications.
 
 
Not applicable.
 

 
     

 
- 4 -
 

SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
February 17, 2015
CVF, LLC
 
By: /s/Richard H. Robb                                 
Name: Richard H. Robb
Title: Manager

 
 
 
  

 
- 5 -